Pulmonx LUNG
NASDAQ LUNG
$1.85 +0.03 (+1.65%)
As of: Oct 21, 2026 · 11:32 AM EDT

Pulmonx (LUNG) Short term Debt (2021 - 2022)

Updated

Pulmonx's Short term Debt was $90,000 in Q4 2022, down 1.1% from $91,000 a year earlier.

Analysis

Pulmonx (LUNG) Short term Debt (2021 - 2022) Analysis & Trends

From Q1 2021 onward, Pulmonx has reported Short term Debt for 5 quarters.

  • In earlier years, Short term Debt was $91,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 260.30 Bn 239.33 Bn 4.88 Bn
2 Abbott Laboratories 170.90 Bn 141.33 Bn 7.27 Bn
3 Danaher 164.81 Bn 148.62 Bn 3.61 Bn
4 Intuitive Surgical 152.46 Bn 131.89 Bn 1.96 Bn
5 Medtronic 119.28 Bn 84.53 Bn 6.34 Bn
6 Stryker 112.91 Bn 99.03 Bn 4.50 Bn
7 Boston Scientific 64.87 Bn 59.63 Bn 3.85 Bn
8 Becton Dickinson 53.24 Bn 50.39 Bn 2.32 Bn
9 Edwards Lifesciences 50.42 Bn 34.43 Bn 1.35 Bn
10 Pulmonx 75.73 Mn -243.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 90,000.00
Dec 31, 2021 91,000.00
Sep 30, 2021 3.31 Mn
Jun 30, 2021 1.89 Mn
Mar 31, 2021 472,000.00
API Access

Pulmonx Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=LUNG&period=max&api_key=YOUR_API_KEY